Evidence shows that cannabis has fewer relative harms than opioids.
作者信息
Lake Stephanie, Socías M Eugenia, Milloy M-J
机构信息
PhD candidate and research associate, BC Centre on Substance Use; UBC School of Population and Public Health, Vancouver, BC.
Assistant professor and research scientist, UBC Department of Medicine; BC Centre on Substance Use, Vancouver, BC.
出版信息
CMAJ. 2020 Feb 18;192(7):E166-E167. doi: 10.1503/cmaj.74120.
Abstract
摘要
相似文献
1
Evidence shows that cannabis has fewer relative harms than opioids.
CMAJ. 2020 Feb 18;192(7):E166-E167. doi: 10.1503/cmaj.74120.
2
Risk and benefit of cannabis prescription for chronic non-cancer pain.
J Addict Dis. 2022 Apr-Jun;40(2):157-167. doi: 10.1080/10550887.2021.1956673. Epub 2021 Aug 2.
3
Medical marijuana laws, substance use treatment admissions and the ecological fallacy.
Addiction. 2020 Jan;115(1):188-189. doi: 10.1111/add.14748. Epub 2019 Nov 13.
4
[Not Available].
Rev Med Suisse. 2022 Jul 20;18(790-2):1474. doi: 10.53738/REVMED.2022.18.790-2.1474.
5
The need for more consistent evidential standards in cannabis policy evaluations.
Addiction. 2018 Aug;113(8):1553-1554. doi: 10.1111/add.14262. Epub 2018 Jun 7.
6
Cannabis for Treatment of Chronic Pain.
Am Fam Physician. 2022 Aug;106(2):202-204.
7
Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment.
Addiction. 2018 Dec;113(12):2259-2260. doi: 10.1111/add.14432. Epub 2018 Sep 24.
8
Potent Marijuana Strains Are Making Teens Sick.
Am J Nurs. 2022 Oct 1;122(10):12. doi: 10.1097/01.NAJ.0000890164.20134.4f.
9
Perspectives on cannabis as a substitute for opioid analgesics.
Pain Manag. 2019 Mar 1;9(2):191-203. doi: 10.2217/pmt-2018-0051. Epub 2019 Jan 25.
10
Medical marijuna laws: Response to Caputi.
Addiction. 2020 Jan;115(1):189-190. doi: 10.1111/add.14833. Epub 2019 Nov 13.
引用本文的文献
1
Inpatient outcomes of rheumatoid arthritis in hospitalized patients using cannabis: data from the National Inpatient Sample.
Proc (Bayl Univ Med Cent). 2025 Mar 24;38(3):259-264. doi: 10.1080/08998280.2025.2473863. eCollection 2025.
2
Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety - Pennsylvania, March 2023-April 2023.
Med Cannabis Cannabinoids. 2024 Jul 17;7(1):119-124. doi: 10.1159/000539956. eCollection 2024 Jan-Dec.
3
Comparative Safety Analysis of Nabilone Versus Opioids: A Population-Based Cohort Study.
J Gen Intern Med. 2024 Nov;39(14):2716-2723. doi: 10.1007/s11606-024-08978-2. Epub 2024 Aug 14.
4
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes.
J Cannabis Res. 2023 Jul 4;5(1):25. doi: 10.1186/s42238-023-00195-8.
5
Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective.
Cannabis Cannabinoid Res. 2023 Oct;8(5):699-702. doi: 10.1089/can.2023.0031. Epub 2023 Mar 31.
6
The association between cannabis and codeine use: a nationally representative cross-sectional study in Canada.
J Cannabis Res. 2022 Sep 9;4(1):49. doi: 10.1186/s42238-022-00160-x.
7
Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018.
Drug Alcohol Depend. 2021 Feb 1;219:108421. doi: 10.1016/j.drugalcdep.2020.108421. Epub 2020 Nov 23.
本文引用的文献
1
Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis.
PLoS Med. 2019 Nov 19;16(11):e1002967. doi: 10.1371/journal.pmed.1002967. eCollection 2019 Nov.
2
Medical cannabis: strengthening evidence in the face of hype and public pressure.
CMAJ. 2019 Aug 19;191(33):E907-E908. doi: 10.1503/cmaj.190509.
3
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
Am J Psychiatry. 2019 Nov 1;176(11):911-922. doi: 10.1176/appi.ajp.2019.18101191. Epub 2019 May 21.
4
High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.
5
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
JAMA Intern Med. 2018 May 1;178(5):667-672. doi: 10.1001/jamainternmed.2018.0266.
6
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Neuropsychopharmacology. 2018 Sep;43(10):2046-2055. doi: 10.1038/s41386-018-0011-2. Epub 2018 Feb 5.
7
Do medical marijuana laws reduce addictions and deaths related to pain killers?
J Health Econ. 2018 Mar;58:29-42. doi: 10.1016/j.jhealeco.2017.12.007. Epub 2018 Feb 3.
8
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report.
Cannabis Cannabinoid Res. 2017 Jun 1;2(1):160-166. doi: 10.1089/can.2017.0012. eCollection 2017.
9
Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.
Drug Alcohol Depend. 2017 Apr 1;173:144-150. doi: 10.1016/j.drugalcdep.2017.01.006. Epub 2017 Feb 21.
10
Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):837-43. doi: 10.15585/mmwr.mm6533a2.
Zotero 插件